Related Articles
Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells
CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro
HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway
Effects of Clostridium difficile toxin A on K562/A02 cell proliferation, apoptosis and multi-drug resistance
With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells